At this year's Annual Scientific Meeting of the American College of Gastroenterology, advances in the treatment of a range of GI disorders—ranging from esophageal disorders to ulcerative colitis—was the focus. ConsultantLive has captured the highlights of the meeting from a primary care perspective and offers “take home” summaries from key presentations.
Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.
A presentation on October 14, 2013, at the American College of Gastroenterology Scientific Session by Joseph A. Murray, MD, FACG (Mayo Clinic)Murray JA. Implications of gluten intolerance and celiac disease in IBS.